MTOR and Decreased liver function: In addition, MCC950, an inhibitor of NLRP3, can inhibit the mammalian targets of rapamycin (mTOR) pathway in aging mice, thereby increasing autophagy and reducing the inflammation response, finally improving liver dysfunction (Marin-Aguilar et al.2020).